bendroflumethiazide has been researched along with Rhabdomyolysis in 1 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
Excerpt | Relevance | Reference |
---|---|---|
"Rhabdomyolysis is a severe condition with an incidence of 28% in hypokalaemic patients." | 1.40 | [Rhabdomyolysis caused by thiazid-induced hypokalaemia]. ( Bach, PT; Raaber, N, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bach, PT | 1 |
Raaber, N | 1 |
1 other study available for bendroflumethiazide and Rhabdomyolysis
Article | Year |
---|---|
[Rhabdomyolysis caused by thiazid-induced hypokalaemia].
Topics: Adult; Bendroflumethiazide; Female; Humans; Hypokalemia; Rhabdomyolysis; Thiazides | 2014 |